bendamustine hydrochloride has been researched along with Cytomegalovirus Infections in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, T; Hamada, T; Hatta, Y; Iizuka, K; Iriyama, N; Koike, T; Kurihara, K; Miura, K; Nakagawa, M; Nakamura, H; Nakayama, T; Takahashi, H | 1 |
| Ancona, G; Chiamenti, M; Codecà, C; Cona, A; d'Arminio Monforte, A; Ferrari, D; Marchetti, G; Marti, A; Merlini, E; Tesoro, D; Tincati, C | 1 |
| Chiba, A; Kurokawa, M; Nakamura, F; Nakazaki, K | 1 |
| Goyle, S; Parikh, P; Singhania, SVK | 1 |
| Chinen, Y; Fuchida, SI; Horiike, S; Iwai, T; Kaneko, H; Kawata, E; Kiyota, M; Kobayashi, T; Kobayashi, Y; Kuroda, J; Matsumoto, Y; Mizutani, S; Nagoshi, H; Nakao, M; Nishigaki, H; Ohshiro, M; Shimazaki, C; Shimura, K; Shimura, Y; Sugitani, M; Takimoto-Shimomura, T; Taniwaki, M; Uchiyama, H; Uoshima, N; Yoshida, M | 1 |
| Kawashima, I; Kirito, K; Mitsumori, T; Nakajima, K; Nozaki, Y; Sueki, Y; Yamamoto, T | 1 |
| Izutsu, K; Maruyama, D; Nisikori, M; Ohmachi, K; Suzuki, T | 1 |
| Aisa, Y; Hasegawa, T; Nakazato, T; Shimazaki, K | 1 |
| Hoot, A; Langevin, J; Lim, SH; Pathapati, S | 1 |
| Boku, S; Hosoda, T; Kagoo, T; Ohashi, K; Ueno, H; Yamamoto, R; Yano, T; Yokoyama, A; Yoneda, M | 1 |
2 review(s) available for bendamustine hydrochloride and Cytomegalovirus Infections
| Article | Year |
|---|---|
[Development of cytomegalovirus antigenemia in 3 patients with B cell lymphoma treated with bendamustine monotherapy].
Topics: Adult; Aged; Antigens, Viral; Antiviral Agents; Bendamustine Hydrochloride; Biomarkers; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Lymphoma, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Opportunistic Infections; Treatment Outcome; Valganciclovir; Virus Activation | 2014 |
[Recommendation for the optimal use of bendamustine in Japan].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Clinical Trials as Topic; Cytomegalovirus Infections; Drug Administration Schedule; Drug Eruptions; Evidence-Based Medicine; Hepatitis B; Humans; Immunocompromised Host; Japan; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Nausea; Nitrogen Mustard Compounds; Opportunistic Infections; Rituximab; Vasculitis | 2014 |
1 trial(s) available for bendamustine hydrochloride and Cytomegalovirus Infections
| Article | Year |
|---|---|
Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytomegalovirus Infections; Dexamethasone; Drug Administration Schedule; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Neutropenia; Rituximab; Salvage Therapy; Young Adult | 2019 |
7 other study(ies) available for bendamustine hydrochloride and Cytomegalovirus Infections
| Article | Year |
|---|---|
Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience.
Topics: Aged; Antiviral Agents; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Infections; Humans; Lymphoma; Retrospective Studies; Risk Factors | 2023 |
Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets.
Topics: Aged; Antineoplastic Agents, Alkylating; Antiviral Agents; B-Lymphocytes; Bendamustine Hydrochloride; CD8-Positive T-Lymphocytes; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Humans; Male; T-Lymphocyte Subsets; Valganciclovir; Waldenstrom Macroglobulinemia | 2019 |
Cytomegalovirus antigenemia and end-organ disease in Japanese patients treated with bendamustine.
Topics: Aged; Aged, 80 and over; Antigens, Viral; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Virus Activation | 2018 |
CMV Pneumonitis following Bendamustine containing Chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Lymphoma, B-Cell; Pneumonia, Viral; Virus Activation | 2017 |
Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Grading; Nitrogen Mustard Compounds; Retrospective Studies; Virus Activation | 2015 |
Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine.
Topics: Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Cytomegalovirus Infections; Female; Gastritis; Humans; Lymphoma, Follicular; Nitrogen Mustard Compounds; Virus Activation | 2012 |
Bendamustine can severely impair T-cell immunity against cytomegalovirus.
Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; T-Lymphocytes | 2013 |